Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Total Liabilities (2016 - 2026)

Insmed's Total Liabilities history spans 17 years, with the latest figure at $1.4 billion for Q1 2026.

  • Quarterly Total Liabilities fell 19.52% to $1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Mar 2026, down 19.52% year-over-year, with the annual reading at $1.5 billion for FY2025, 12.32% down from the prior year.
  • Total Liabilities came in at $1.4 billion for Q1 2026, down from $1.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.8 billion in Q2 2024 to a low of $1.0 billion in Q2 2022.
  • The 5-year median for Total Liabilities is $1.6 billion (2022), against an average of $1.5 billion.
  • Year-over-year, Total Liabilities surged 110.58% in 2022 and then plummeted 30.55% in 2025.
  • Insmed's Total Liabilities stood at $1.6 billion in 2022, then increased by 5.95% to $1.7 billion in 2023, then rose by 4.7% to $1.7 billion in 2024, then decreased by 12.32% to $1.5 billion in 2025, then dropped by 10.13% to $1.4 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Total Liabilities are $1.4 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025).